LSD molecule:

Image from PubChem

LSD Clinical Trials


Effect of Ketanserin After LSD Administration on the Acute Response to LSD in Healthy Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04558294

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Recruiting

Start Date: October 16, 2020

Last Update: October 27, 2020

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: LSD (lysergic acid diethylamide) is a serotonergic (5-HT) hallucinogen widely used for recreational and/or ethnomedical purposes. LSD is thought to induce its prototypical psychedelic effects primarily via stimulation of the 5-HT2A receptor. This study investigates whether an LSD experience can be attenuated and shortened using 5-HT2A receptor antagonist ketanserin administration after LSD once the psychedelic effects have established.

Conditions:
  • Healthy


Total execution time in seconds: 0.15972208976746